Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$1.2M
Filings
23
Firms Hired
3
Active Period
2025–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Preserving Patient Access to Home Infusion Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 2172
Preserving Patient Access to Home Infusion Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 2172
Preserving Patient Access to Home Infusion Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 2172
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5031
Preserving Patient Access to Home Infusion Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: S. 1058
Preserving Patient Access to Home Infusion Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: S. 1058
Preserving Patient Access to Home Infusion Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: S. 1058
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: S. 3159
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: S. 3159
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health and hospice agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 2172/S. 1058 Preserving Access to Home Infusion Act.
Client expense: — · Firm income: $80,000
Matched citations: S. 3159
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to pharmacy-related Medicare payments, including H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · third_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to pharmacy-related Medicare payments, including H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 3159
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $80,000
Matched citations: S. 3159
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $80,000
Matched citations: S. 3159
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $80,000
Matched citations: S. 3159
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to pharmacy-related Medicare payments, including H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · second_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to pharmacy-related Medicare payments, including H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 3159
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to pharmacy-related Medicare payments, including H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · first_quarter · Firm: AKIN GUMP STRAUSS HAUER FELD
Issues related to pharmacy-related Medicare payments, including H.R. 5031/S. 3159 - Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 3159
Preserving Patient Access to Long-Term Care Pharmacies Act
2026 · first_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to long term care pharmacy sustainability and access; issues related to Medicare-certified home health agency function; issues related to access improvement for home infusion therapy services; H.R. 5031/S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5031
Source: Senate LDA